Ads
related to: vertex pharmaceuticals diabetes- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- News
Search results
Vertex Pharmaceuticals: Buy at the High?
Motley Fool· 2 years agoVertex Pharmaceuticals (NASDAQ: VRTX) has a lot going on these days. The biotech company is developing two candidates that could make it even stronger in...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 4 weeks agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this...
Is Vertex Pharmaceuticals a Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has beaten the bear market by far this year: The stock is heading for a 30% gain. Vertex is the global leader in...
Where Will Vertex Pharmaceuticals Be in 10 Years?
Motley Fool· 6 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has come a long way in the past ten years. In a little over a decade, the company has built a cystic fibrosis (CF)...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2023 Earnings Call Transcript May 1, 2023...
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has been generating billion-dollar revenue for years, thanks...
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Zacks via Yahoo Finance· 1 month agoVertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem...
Vertex (VRTX) Stock Poised Well for Growth in 2023: Here's Why
Zacks via Yahoo Finance· 12 months agoVertex Pharmaceuticals (VRTX) stock is likely to be driven by several catalysts this year. Multiple...
IBD 50 Stocks To Watch: Vertex Pharmaceuticals In Buy Zone As Firm Gets On A Roll
Investor's Business Daily· 1 year agoBiotech stock Vertex Pharmaceuticals is in the buy zone of a base. Vertex stock is Tuesday's IBD 50...
FDA Accepts Vertex (VRTX), CRISPR's BLA Filings for Exa-Cel
Zacks via Yahoo Finance· 12 months agoVertex Pharmaceuticals VRTX and CRISPR Therapeutics CRSP announced that the FDA has accepted their...
Ad
related to: vertex pharmaceuticals diabetes
